Wegovy Rash Pictures and What the Skin Reactions Actually Look Like

Step 1: Recognise the most common picture, injection-site redness

The rash most people search for after starting Wegovy sits directly at the injection point. It typically looks like a small patch of pink or red skin, sometimes with a raised edge, a little like a mild insect bite. The area may feel warm or itchy for a few hours. In photographs shared in clinical monitoring contexts, these reactions are usually under two centimetres across, fade within 24 to 48 hours, and shift each week as patients rotate between the abdomen, thigh and upper arm.

Rotating injection sites is the single most effective step for reducing this reaction. If you are always injecting in the same spot, the skin becomes sensitised, and the local reaction tends to grow more pronounced over time. The Wegovy overview on our treatment pages has practical detail on injection technique. Ensuring the pen has reached room temperature before use also helps, injecting cold semaglutide straight from the fridge is a frequent cause of unnecessary stinging and local redness.

The NHS medicines page for semaglutide lists injection-site reactions among the common side effects (meaning they affect roughly one in ten people or more) and frames them as generally not serious.

Step 2: Notice if the reaction has spread beyond the injection site

A different pattern emerges when the immune system responds more broadly. Instead of a localised mark, you might notice raised, blotchy welts that appear on the arms, torso or legs, classic urticaria, commonly called hives. The individual welts can be pale in the centre with a redder border, and they tend to be itchy rather than painful. You can browse Wegovy pictures from clinical and post-marketing sources to see how this presentation compares to localised injection-site reactions. Widespread hives are less common than local reactions but matter more clinically.

They can indicate the body is mounting a broader allergic response to semaglutide, and a prescriber needs to know about them. Do not simply wait and hope they settle. Contact your prescribing team, for nume patients that means our priority aftercare line, seven days a week. You can read more about whether Wegovy can cause a rash and how frequently it occurs.

Mild generalised itching without visible hives is also reported, and is usually managed by the prescriber adjusting timing, hydration or, in some cases, antihistamine use under guidance.

Step 3: Know the signs that require same-day emergency help

A small number of people experience a severe hypersensitivity or anaphylactic reaction. The visual cues here are quite different from the localised site reaction: a rapidly spreading rash or flushing across the face and neck, swelling around the lips, tongue or throat, and skin that looks blotchy or mottled. This presentation typically comes with other symptoms, difficulty swallowing, a drop in blood pressure causing dizziness, or trouble breathing.

This is a 999 situation. Do not drive yourself; do not wait to see if it improves. Severe allergic reactions are listed in the Wegovy summary of product characteristics as a reason to stop treatment immediately and seek emergency care. Semaglutide is a Black Triangle medicine, meaning the MHRA actively collects safety data on it, any suspected reaction like this should also be reported via the Yellow Card scheme once you are safe.

For a broader look at semaglutide's side-effect profile, including GI reactions that sometimes accompany skin symptoms, the detailed semaglutide rash guide covers the overlap.

Step 4: Document and discuss before your next dose

If you experience any skin reaction (even a mild one) photograph it and note the date, the injection site used, and how long it lasted. This information is genuinely useful to a prescriber deciding whether to continue treatment, adjust the dose schedule, or recommend a different approach. A picture taken close to the reaction is far more informative than a description from memory two weeks later.

Patients transferring to semaglutide from tirzepatide, or who have a background history of skin allergies or eczema, sometimes need extra monitoring in the early weeks. Our prescribers discuss this during the review process. If you are considering starting Wegovy and want to understand what clinical assessment involves, the free consultation page explains every step.

It is also worth knowing that the pen you receive arrives via DPD tracked delivery in plain, unbranded packaging, so nothing about the box signals its contents. Storing the pen at 2–8°C as directed (the patient information leaflet gives the exact room-temperature window) keeps the medicine stable and reduces the chance of a compromised injection causing unnecessary skin irritation. You can find a fuller picture of how the medicine works on the semaglutide treatment page, or explore what to do when a Wegovy rash appears for next-step guidance.